---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-268518"
form_type: "8-K"
ticker: "BIOA"
cik: "0001709941"
company_name: "BioAge Labs, Inc."
filed_at: "2026-06-12T12:00:16+00:00"
generated_at: "2026-06-12T12:06:19.845246+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BioAge Labs shareholders elect three Class II directors, ratify KPMG at annual meeting

## Summary
- Class II directors elected: Patrick Enright (30.1M for, 1.2M withheld), James Healy (25.5M for, 5.8M withheld), Rekha Hemrajani (27.8M for, 3.4M withheld).
- Ratification of KPMG as independent auditor for FY2026 passed with 36.6M for, 1.3K against, 25.1K abstentions.
- Broker non-votes of 5.3M on director election proposals did not affect outcome.
- All directors serve three-year terms expiring at 2029 annual meeting.

## SEC filing metadata
- accession: 0001193125-26-268518
- form_type: 8-K
- ticker: BIOA
- cik: 0001709941
- company_name: BioAge Labs, Inc.
- filed_at: 2026-06-12T12:00:16+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1709941/000119312526268518/0001193125-26-268518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1709941/000119312526268518/bioa-20260610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-268518
- JSON: https://secwatch.observer/filing/0001193125-26-268518.json
- Plain text: https://secwatch.observer/filing/0001193125-26-268518.txt

## Key facts
- Shareholder Votes
  BioAge Labs, Inc. shareholders approved Election of three Class II Directors, Patrick Enright, James I. Healy, and Rekha Hemrajani, each to serve a three-year term at the 2026-06-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: 1. The election of three Class II Directors, Patrick Enright, M.B.A., James I. Healy, M.D., Ph.D., and Rekha Hemrajani, M.B.A., each to serve a three-year term, which will expire at the 2029 Annual Meeting of Stockholders and until such time as their respective successors have been duly elected and qualified or until such director’s earlier resignation or removal. The vote tally was as follows: Nominees Shares For Shares Withheld Broker Non-Votes Patrick Enright, M.B.A. 30,075,928 1,184,271 5,327,405 James I. Healy, M.D., Ph.D. 25,499,205 5,760,994 5,327,405 Rekha Hemrajani, M.B.A. 27,826,781 3,433,418 5,327,405
  evidence_url: https://www.sec.gov/Archives/edgar/data/1709941/000119312526268518/0001193125-26-268518-index.htm
- Shareholder Votes
  BioAge Labs, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: 2. The ratification of the appointment of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. The vote tally was as follows: Shares For Shares Against Shares Abstaining 36,561,171 1,305 25,128
  evidence_url: https://www.sec.gov/Archives/edgar/data/1709941/000119312526268518/0001193125-26-268518-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.